© 2018 Jamaican Medical Cannabis Corporation. All rights reserved.

info@jamaicanmedicann.com | 100 King St. W, Suite 3400 Toronto, ON, Canada

  • Twitter

JMCC: SETTING THE CERTIFICATION STANDARD

JMCC has embarked on one of the most ambitious certification programs in the medical marijuana industry. Our near-term objectives are to obtain:

  • GMP Certification: GMP (Good Manufacturing Practices) are the practices required in order to adhere to the guidelines recommended for the manufacture and sale of food, drug products, and active pharmaceutical products. GMP is overseen by regulatory bodies all over the world.

  • GDP certification: GDP (Good Distribution Practices) is a quality-measurement system for warehouse and distribution centres dedicated to medicinal products. Internationally accepted pharmaceutical GDP regulations require distributors of pharmaceutical products to align their operations with these standards to ensure that consistent quality management systems are in place throughout the company’s entire supply chain – from the delivery of raw materials to manufacturing/processing facilities and on to the final shipment of finished medicines to the end user;

  • ISO 9001 certification: the international standard for quality management systems (QMS). Achieving this standard will demonstrate our ability to consistently provide products and services that meet customer and regulatory requirements;

  • ISO 14001 certification: this sets out the criteria for an effective environmental management system. Achieving this standard will help to demonstrate our commitment to acting as conscientious stewards of the environment in everything we do;

  • GLP and ISO 17025 certification: GLP (Good Laboratory Practices) and ISO 17025 are the current international standards for excellence in lab operations and testing processes;

  • Fair Trade Organization (FTO) certification: Fair Trade standards are designed to tackle poverty and empower producers in the poorest countries in the world. JMCC will work with FTO authorities worldwide on the inclusion of medical cannabis as a covered product category and, in the meantime, aim to meet all FTO principles.